BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 19 filers reported holding BELLEROPHON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $118,000 | -27.6% | 337,988 | 0.0% | 0.39% | -16.4% |
| Q3 2019 | $163,000 | -44.4% | 337,988 | -31.0% | 0.47% | +108.0% |
| Q2 2019 | $293,000 | +132.5% | 489,550 | +153.1% | 0.23% | +253.1% |
| Q1 2019 | $126,000 | +72.6% | 193,456 | +185.9% | 0.06% | +93.9% |
| Q3 2018 | $73,000 | -79.2% | 67,660 | -53.3% | 0.03% | -75.4% |
| Q2 2018 | $351,000 | -15.2% | 145,000 | -27.1% | 0.13% | -13.5% |
| Q1 2018 | $414,000 | +102.0% | 199,000 | +150.6% | 0.16% | +98.7% |
| Q4 2017 | $205,000 | – | 79,421 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLINSKY STEVEN B | 4,859,885 | $44,614,000 | 20.33% |
| Senator Investment Group LP | 448,679 | $4,119,000 | 0.04% |
| HIGHLAND CAPITAL MANAGEMENT LP | 162,177 | $1,489,000 | 0.03% |
| Baker Brothers Advisors | 350,000 | $3,213,000 | 0.03% |
| Alyeska Investment Group, L.P. | 94,131 | $864,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 30,000 | $275,000 | 0.01% |
| FMR LLC | 1,302,070 | $11,953,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,427 | $142,000 | 0.00% |
| BlackRock Investment Management, LLC | 846 | $8,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 17,290 | $159,000 | 0.00% |